151813-29-5

Basic information

• Product Name: BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE
• Synonyms: BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE;4,5,6,7-Tetrahydro-4,7-ethanoisobenzofuran-1,3-dione;Bicyclo2.2.2üoct-2-ene-2,3-dicarboxylic anhydride, 98%
• CAS NO: 151813-29-5
• Molecular Formula: C10H10O3
• Molecular Weight: 178.18
• Mol File: 151813-29-5.mol

Chemical Properties

• Melting Point: 158-160°C
• Boiling Point: 337.9°Cat760mmHg
• Flash Point: 164.6°C
• Appearance: /
• Density: 1.34g/cm³
• Vapor Pressure: 0.000102mmHg at 25°C
• Refractive Index: 1.572
• Water Solubility: Insoluble in water.
• Sensitive: Moisture Sensitive
• BRN: 167495
• CAS DataBase Reference: BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE(CAS DataBase Reference)
• NIST Chemistry Reference: BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE(151813-29-5)
• EPA Substance Registry System: BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE(151813-29-5)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 151813-29-5(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE is used as a reactive intermediate for the synthesis of complex organic molecules due to its ability to undergo various chemical reactions to form different derivatives.
Used in Polymer and Resin Production:
In the chemical industry, BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE is used as a key component in the production of certain polymers and resins, contributing to the development of materials with specific properties.
Used in Pharmaceutical Industry:
BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE is utilized as a building block in the pharmaceutical industry for the creation of new drug molecules, taking advantage of its unique molecular structure and reactivity.
Used in Agrochemical Industry:
BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE also finds application in the agrochemical sector, where it is employed in the synthesis of various agrochemical products, potentially enhancing crop protection and yield.
Used in Materials Science:
Due to its unique molecular structure and reactivity, BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE has potential applications in the field of materials science, where it can contribute to the development of novel materials with specific characteristics.
It is important to handle BICYCLO[2.2.2]OCT-2-ENE-2,3-DICARBOXYLIC ANHYDRIDE with care, as it can be caustic and hazardous if not properly managed, ensuring safety in its applications across various industries.

InChI:InChI=1/C10H10O3/c11-9-7-5-1-2-6(4-3-5)8(7)10(12)13-9/h5-6H,1-4H2

Upstream product

• 1165952-92-0 cyclohexa-1,4-diene 
• 1165952-91-9 cyclohexa-1,3-diene 
• 762-42-5 dimethyl acetylenedicarboxylate 
• 64-19-7 acetic acid 
• 108-31-6 maleic anhydride 
• 950-65-2 dimethyl bicyclo[2.2.2]octa-2,5-diene-2,3-dicarboxylate 
• 41216-85-7 2,3-bis(methoxycarbonyl)-bicyclo(2.2.2)oct-2-ene 

Downstream Products

• 202823-67-4 3,6-dichloro-4,5-diazatricyclo[6.2.2.2,7]dodeca-2⁽⁷⁾,3,5-triene 
• 1560642-62-7 C₂₈H₃₂ClN₅O₂ 
• 1560642-66-1 C₄₄H₅₂N₈O₄ 
• 1560649-14-0 C₄₈H₅₈N₁₀O₆ 

Relevant articles and documents

Unusual Stereoselectivity in the Diels-Alder Addition of Cyclpentadiene with the Bicyclooctene Nucleus

Cyclopentadiene adds to the substituted and electronically activated double bond of bicycloocta-2,5-diene-2,3-dicarboxylic anhydride with pronounced endo selectivity.Only two of the four possible stereoisomers were formed.The stereochemical course of the reaction was determined by X-ray crystallography and by a combination of chemical and sppectroscopic techniques.

INHIBITORS OF INFLUENZA VIRUS REPLICATION, APPLICATION METHODS AND USES THEREOF

The invention provides a novel class of compounds as inhibitors of influenza virus replication, preparation methods thereof, pharmaceutical compositions containing these compounds, and uses of these compounds and pharmaceutical compositions thereof in the treatment of influenza.

Bridged Ring compounds As Hepatitis C Virus (HCV) Inhibitors And Pharmaceutical Applications Thereof

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.

BRIDGED RING COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS AND PHARMACEUTICAL APPLICATIONS THEREOF

Provided herein is a compound having Formula (I), or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, which can be used for treating HCV infection or a HCV disorder. Also provided herein are pharmaceutical compositions comprising the compounds disclosed herein, which can be used for treating HCV infection or a HCV disorder.

Novel saturated [2.2.2] dicarboxylate salt thermoplastic nucleators and thermoplastic compositions thereof

Compounds of and compositions comprising specific salts of saturated [2.2.2] dicarboxylate in order to provide highly desirable properties within thermoplastic (e.g., polyolefin) articles are provided. The inventive salts and derivatives thereof are useful as nucleating and/or clarifying agents for such thermoplastics, are easy to produce and handle, and relatively inexpensive to manufacture. Such compounds induce high peak crystallization and improved stiffness within thermoplastics. Also, thermoplastic compositions comprising such novel nucleating agents exhibit improved heat distortion properties and clarity levels in comparison with the closest unsaturated salt nucleating agents. Thermoplastic additive compositions and methods of producing thermoplastics with such compounds are also contemplated within this invention.